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1. Introduction 
l$lt 
The tertiary butyl derivative H-Thr-Phe-Pro-OH 
had been shown to be a potent competitive inhibitor 
of leucine aminopeptidase from swine kidney [ 11. 
It was shown that the voluminous hydrophobic 
group, protecting the hydroxy function of the 
threonine side chain was essential for the resistance 
of this peptide to enzymatic hydrolysis. 
To achieve better understanding of the molecular 
properties of this inhibitor, the compounds 
But But But 
H-fhr-OH, H-ihr-NH2 and H-ihr-Phe-OH were 
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as III, and 
H-Thr-Phe-Pro-OH as IV. 
Laucine aminopeptidase, EC 3.4.1 .l:LAP. 
Leucine aminopeptidase from bovine eye lens: RAP. 
Aminopeptidase M, EC 3.4.1.2:APM. 
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prepared and their interaction with the enzyme 
studied. 
It is shown in this report that competitive inhibi- 
tors derived from O-tertiary butyl-threonine can be 
used to explore relationships between different amino. 
peptidases from animal tissue. 
2. Materials and methods 
LAP was obtained from Worthington Biochemicals, 
Freehold, New Jersey, USA. RAP was a gift of Prof. 
H. Hanson, Martin Luther UniversitBt, Halle, DDR. 
AMP was from RGhm and Haas GmbH, Darmstadt, 
Germany. The enzymes were used without further 
purification. Protein concentrations were estimated 
prior to activation of LAP and RAP from the absorb- 
ance of the enzyme solution at 280 and 260 nm. The 
enzyme catalyzed hydrolysis of leucine p-nitroanilide 
was determined from the increase in absorbance at 
405 nm, as measured on an Eppendorf spectrophoto- 
meter. The hydrolysis of peptides by LAP and RAP 
was studied with the aid of an automatic Beckman 
analyzer, model 121. APM was assayed according to 
Wachsmuth et al. [2]. LAP and RAP were activated 
by incubation at 40” in the usual activation system 
(Of05 M Tris-buffer PH 8.5, 5 mM Mg& and 2 mM 
MnCl,) at a protein cont. of 1 mg/ml. The incubation1 
period to obtain full activity was about 20 min for 
RAP, whereas nearly 2 hr were required to activate 
the swine kidney enzyme. 
Both aminopeptidases were assayed in 0.05 M Tris- 
buffer pH 8.5, 5 mM MgCl,, at 30”. The relative 
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activities with 1 mM leucine p-nitroanilide were 
1 (UP):3.8 (RAP): 1.8 (APM at 37” and pH 7.0). 
The Dixon method [3] was used to calculate in- 
hibition constants (&-values). 
Peptide synthesis: chemical and physical properties 
of the threonine(tert.butyl)-compounds will be given 
elsewhere. 
3. Results 
Neither the ammo acid 1, nor its amide II, com- 
peted effectively with the substrate, 1 mM leucine 
p-nitroanilide, for the active site of LAP. 
Gradually increasing concentrations, ranging from 
lo@ M to 10e3 M, of I and II were added to a 
1 Op7 M enzyme solution with substrate ( 1 0m3 M) 
present. Even at the highest concentration indicated, 
no inhibition was observed. In contrast to this, 
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Fig. 1. Lineweaver-Burk plot for the enzyme catalyzed 
hydrolysis of leucine p-nitroanilide by the bovine lens enzyme: 
10 pg of protein, 5 min of incubation at 30”. v is expressed 
in nmoles 4-nitroaniline formed. ( o-+--o) Uninhibited; 
But 
(~--A--A) 0.01 mM H-Thr-Phe-Pro-OH; 
But 
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Fig. 2. Digestion of threonine(tert.butyl)-derivatives by 
leucine aminopeptidase from bovine lens. 1.6 X 10e6 M 
enzyme was incubated with 25 mM substrate solutions at 30”. 
The reaction was terminated at various intervals of time by 
adding 0.38 N sodium citrate buffer, pH 2.2. The amount of 
N-terminal amino acid liberated was determined by amino 
acid analysis. 
hibition. Kinetic analysis showed that III acted as a 
pure competitive inhibitor of LAP. The potency of 
the dipeptide as an inhibitor was distinctly lower, 
compared with that of the tripeptide IV. A K,-value 
of 2.5 X 106 M was found. The &-value for the tri- 
peptide, as determined earlier [ 11, is 1 .O X 10m5 M. 
With the enzyme from bovine eye lens, the same 
observations were made in competition experiments. 
Amino acid and amide were no inhibitors, but dipep- 
tide and tripeptide turned out to be strong, competi- 
tive inhibitors of RAP. The clearly competitive inter- 
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action of the inhibitors with RAP is illustrated for 1V 
in fig. 1. 
The $-values found for III and IV were identical 
with those that had been determined for the swine 
kidney LAP (table 1). 
None of the threonine(tert.butyl)-derivatives had 
any detectable effect on APM, the enzyme from the 
microsomal fraction of swine kidney. 
Added in various concentrations up to 1 0p3 M, 
none of the compounds I-IV was able to inhibit the 
reaction of about 10e7 M APM with its substrate, 
lO-3 M leucine p-nitroanilide. 
A qualitative digestion experiment carried out with 
25 mM peptide solutions and an enzyme concentra- 
tion of 1O-6 M, indicated that neither III or IV was 
degraded by APM at a significant rate. 
Similar results were also obtained with a bacterial 
aminopeptidase of broad specificity, AP I from 
Bacillus stearothermophilus [4]. 
This enzyme liberated only minor quantities of 
N-terminal H-Thr-OH from III and IV after prolonged 
incubation near its optimum temperature for substrate 
binding and catalysis, 55”. As APM, it was not in- 
hibited by 1, II, III or IV at 10W3 M. 
A quantitative digestion study with LAP and RAP 
indicated that the threonine(tert.butyl)-derivatives 
II-IV, represented different stages of resistance to 
hydrolysis by leucine aminopeptidase (fig. 2). 
It must be noted that even the rate of hydrolysis 
for the amide (5-9% of a 25 mM substrate solution 
was hydrolyzed by l-2 X lo@ M enzyme in 1 hr at 
30”) is very low compared with that of a normal 
peptide-substrate. 
The rate of hydrolysis of the dipeptide III is 3-5 
times lower than that of the amide. About 1 molecule 
in 1000 of III is cleaved by leucine aminopeptidase 
per hr at 30”, to yield 1 and H-Phe-Pro-OH (fig. 2). 
4. Discussion 
The interaction of the threonine(tert.butyl)-com- 
pounds I-IV with LAP and RAP, as summarized in 
table 1, is compatible with the idea that leucine 
aminopeptidase from swine kidney and from bovine 
eye lens are two forms of the same enzyme. This is 
consistent with the conclusions of Hanson et al. [ 51, 
who suggested a close relationship between the 
“classical” leucine aminopeptidase and the bovine 
lens enzyme on the basis of immunological evidence 
and specificity. 
According to Glasser et al. [6], RAP is not a lens 
specific protein, as immunologically related enzymes 
occur in various tissues of vertebrates. 
The competitive inhibitors III and IV might serve 
here to explore the similarity of the active site region 
of various forms of leucine aminopeptidase which may 
show considerable variations in their physico-chemical 
properties, depending on tissue and species of origin. 
The failure of APM and AP I to cleave II, III and 
IV at a significant rate, and the inefficiency of the 
peptides as inhibitors of these aminopeptidases, is best 
interpreted by a very low or lacking affinity of the 
threonine(tert.butyl)-derivatives for these enzymes. 
From this inhibition study, a close relationship 
between the swine kidney enzymes LAP and APM 
must be denied. 
The high affinity of IV to leucine aminopeptidase, 
and in addition the potentially high resistance of the 
peptide to the catalytic action of other proteolytic 
enzymes, make it promising to use the inhibitor in 
studies on the biological role of leucine aminopeptidase 
in various tissues. 
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